OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Searching for the “final proof” of schizophrenia	85
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	81
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	76
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	72
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	63
Meta-analysis of a family history of diabetes in schizophrenia	61
Going the extra mile? The influence of Amisulpride on effort-based decisions	57
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics	54
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	52
Identification of ultra-rare missense mutations associated with familial schizophrenia by whole-exome sequencing	52
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	51
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	50
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	49
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	49
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	45
Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: A case report	43
Frequency of clinical appointments in subjects with emergent suicidal ideation	42
Shortening telomere is associated with psychotic dimensions in the general population	42
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	38
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	38
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	37
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	37
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	37
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	37
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	37

Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	36
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	36
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	36
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	35
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	34
Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study	34
Gut microbial changes of patients with psychotic and affective disorders: A systematic review	33
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	33